Electrical Stun Gun and Modern Implantable Cardiac Stimulators: Update for a New Stun Gun Model.


Journal

Health physics
ISSN: 1538-5159
Titre abrégé: Health Phys
Pays: United States
ID NLM: 2985093R

Informations de publication

Date de publication:
01 03 2021
Historique:
pubmed: 22 10 2020
medline: 29 12 2021
entrez: 21 10 2020
Statut: ppublish

Résumé

In 2017, the Italian National Institute of Health conducted a study to evaluate the potential risks of Conducted Electrical Weapons (CEW, AKA "stun guns") for users bearing a pacemaker (PM) or an implantable cardioverter defibrillator (ICD). The study addressed two specific models of stun guns: the TASER model X2 and AXON model X26P. In 2019, the same experimental protocol and testing procedure was adopted to evaluate the risk for another model of stun gun, the MAGEN model 5 (MAGEN, Israel). The MAGEN 5 differs from the previous stun guns tested in terms of peak voltage generated, duration of the shock, and trigger modality for repeated shocks. This note is an update of the previous study results, including the measurements on the MAGEN 5 stun gun. Despite the differences between the stun gun models, the effects on the PM/ICD behavior were the same as previously observed for the TASER stun guns.

Identifiants

pubmed: 33086265
pii: 00004032-202103000-00012
doi: 10.1097/HP.0000000000001332
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-349

Informations de copyright

Copyright © 2020 Health Physics Society.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Mattei E, Censi F, Calcagnini G. Electrical stun gun and modern implantable cardiac stimulators. Health Phys 116:18–26; 2019. DOI:10.1097/HP.0000000000000942.
doi: 10.1097/HP.0000000000000942

Auteurs

Eugenio Mattei (E)

Italian National Institute of Health, Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH